From: A controlled trial of the effectiveness of internet continuing medical education
CME ACTIVITY | Participants | Non-participants | Effect size | ||||
---|---|---|---|---|---|---|---|
 | N | Mean % evidence-based response | SD | N | Mean % evidence-based response | SD |  |
Psychiatry | Â | Â | Â | Â | Â | Â | Â |
Identifying patients with prodromal schizophrenia | 35 | 73 | 12 | 28 | 49 | 16 | 1.76 |
Treatment nonadherence among individuals with schizophrenia | 52 | 71 | 17 | 47 | 54 | 21 | 0.90 |
Treatment resistant schizophrenia | 50 | 77 | 18 | 50 | 60 | 15 | 1.08 |
Reducing suicide risk in patients with schizophrenia | 49 | 81 | 21 | 46 | 59 | 27 | 0.92 |
Recognizing and preventing abuse of rapid-onset opioids | 50 | 68 | 21 | 57 | 48 | 21 | 0.93 |
Detecting autism in a toddler | 100 | 68 | 19 | 102 | 50 | 22 | 0.85 |
Hyperactivity or autism | 101 | 61 | 19 | 95 | 47 | 20 | 0.73 |
Infectious disease | Â | Â | Â | Â | Â | Â | Â |
Maximizing therapeutic success in an era of increasing antibiotic resistance | 43 | 73 | 27 | 43 | 51 | 28 | 0.80 |
The role of antibiotics in serious hospital acquired infections | 47 | 87 | 20 | 54 | 71 | 19 | 0.82 |
Fungal infection in the immunocompromised patient | 47 | 68 | 21 | 39 | 54 | 21 | 0.65 |
Urology | Â | Â | Â | Â | Â | Â | Â |
Prostate cancer | 26 | 71 | 24 | 28 | 49 | 19 | 0.28 |
Lower urinary tract symptoms in men | 24 | 74 | 23 | 24 | 58 | 20 | 0.77 |
Evaluation and treatment of overactive bladder | 41 | 74 | 29 | 45 | 63 | 28 | 0.37 |
Erectile dysfunction and cardiovascular disease | 29 | 63 | 14 | 25 | 57 | 22 | 0.32 |
Cardiology | Â | Â | Â | Â | Â | Â | Â |
Statin efficacy and prevention of recurrent stroke | 22 | 83 | 11 | 22 | 60 | 16 | 1.62 |
Diabetes, Metabolic Syndrome and very low cholesterol | 59 | 88 | 21 | 59 | 72 | 30 | 0.62 |
Statins in the treatment of heart failure | 50 | 60 | 18 | 49 | 45 | 19 | 0.83 |
Advances in hypertension | 22 | 82 | 18 | 22 | 58 | 27 | 1.04 |
Medical adherence | 22 | 55 | 22 | 22 | 38 | 16 | 0.89 |
Analysis of latest trial data points to new guidelines & restructured hypertension therapy | 50 | 85 | 19 | 49 | 59 | 25 | 1.04 |
Neurology | Â | Â | Â | Â | Â | Â | Â |
The role of MRI in multiple sclerosis diagnosis and management | 53 | 64 | 21 | 53 | 46 | 19 | 0.89 |
Breakthrough pain | 73 | 75 | 27 | 73 | 48 | 29 | 0.98 |
Rheumatology | Â | Â | Â | Â | Â | Â | Â |
Risks and benefits of COX-2 selective inhibitors | 85 | 70 | 23 | 98 | 62 | 24 | 0.36 |
Women's health | Â | Â | Â | Â | Â | Â | Â |
Contraception today | 18 | 79 | 21 | 21 | 57 | 20 | 1.12 |